Sverige - svenska - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - itrakonazol - kapsel, hård - 100 mg - sockersfärer hjälpämne; itrakonazol 100 mg aktiv substans - itrakonazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

mcneil sweden ab - famotidin; kalciumkarbonat; magnesiumhydroxid - tuggtablett - famotidin 10 mg aktiv substans; glukosmonohydrat hjälpämne; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; magnesiumhydroxid 165 mg aktiv substans; kalciumkarbonat 800 mg aktiv substans - kombinationer

Europeiska unionen - svenska - EMA (European Medicines Agency)

bayer ag - riociguat - hypertoni, lungformig - antihypertensiva medel mot pulmonell arteriell hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekt har visats i ett pah befolkning, inklusive aetiologies av idiopatisk eller ärftlig polycykliska aromatiska kolväten eller pah som associeras med bindvävssjukdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Europeiska unionen - svenska - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - carcinom, non-small cell lung - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

consilient health limited - kalciumkarbonat; kolekalciferol - tuggtablett - 500 mg/800 ie - sackaros hjälpämne; kolekalciferol 800 ie aktiv substans; aspartam hjälpämne; sorbitol hjälpämne; kalciumkarbonat 1250 mg aktiv substans; xylitol hjälpämne; isomalt hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

consilient health limited - kalciumkarbonat; kolekalciferol - tuggtablett - 500 mg/2000 ie - aspartam hjälpämne; kolekalciferol 2000 ie aktiv substans; sackaros hjälpämne; xylitol hjälpämne; isomalt hjälpämne; kalciumkarbonat 1250 mg aktiv substans; sorbitol hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatit c, kronisk - antivirala medel för systemisk användning - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 och 5.

Europeiska unionen - svenska - EMA (European Medicines Agency)

gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatit c, kronisk - antivirala medel för systemisk användning - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 och 5. för hepatit c-virus (hcv) av genotyp-specifik aktivitet (se avsnitt 4. 4 och 5.

Europeiska unionen - svenska - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatit c, kronisk - antivirala medel för systemisk användning - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (se avsnitt 4. 2, 4. 4 och 5.

Europeiska unionen - svenska - EMA (European Medicines Agency)

viiv healthcare b.v. - maravirok - hiv-infektioner - antivirala medel för systemisk användning - celsentri, in combination with other antiretroviral medicinal products, is indicated for treatment experienced adults, adolescents and children of 2 years of age and older and weighing at least 10 kg infected with only ccr5-tropic hiv-1 detectable,.